IVL vs ELCA for Stent Underexpantsion (IVL-ELCA DRAGON)
NCT ID: NCT06276114
Last Updated: 2024-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
121 participants
OBSERVATIONAL
2020-08-01
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary efficacy endpoint was device success (technical success with a final stent expansion ≥ 80%). Thirty days device-oriented composite endpoint (DOCE: cardiac death, target lesion revascularization, or target vessel myocardial infarction) was the secondary endpoint.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IVL for Stent Underexpantsion
NCT05112250
Prospective Registry on Intravascular Lithotripsy
NCT06577038
Intravascular Balloon Lithotripsy in Left Main Stem Percutaneous Coronary Intervention
NCT04319666
Coronary Calcification Study - Intravascular Lithotripsy for Calcified Lesions
NCT04428177
Clinical Trial on the Treatment of Stent Underexpansion Caused by Calcification Using Intravascular Lithotripsy
NCT06521905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Consecutive patients with stent underexpantsion treated with IVL
Stent Underexpansion
Stent underexpansion was diagnosed as stent expansion of \<80% assessed with intravascular imaging.
Consecutive patients with stent underexpantsion treated ELCA
Stent Underexpansion
Stent underexpansion was diagnosed as stent expansion of \<80% assessed with intravascular imaging.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stent Underexpansion
Stent underexpansion was diagnosed as stent expansion of \<80% assessed with intravascular imaging.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Silesia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wojciech Wańha
MD, PhD, Prof. Ass.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unit of Structural Interventional Cardiology, Department of Clinical and Experimental Medicine, Careggi University Hospital
Florence, , Italy
Fabrizio D'Ascenzo
Turin, , Italy
Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital
Bialystok, , Poland
First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland
Gdansk, , Poland
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
Katowice, , Poland
Jacek Legutko
Krakow, , Poland
Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
Krakow, , Poland
1st Military Hospital in Lublin, Lublin, Poland
Lubin, , Poland
Department of Cardiology, Copper Health Centre (MCZ)
Lubin, , Poland
Clinical Department of Interventional Cardiology, Medical University of Lublin
Lublin, , Poland
Department of Cardiology, University Hospital, Institute of Medical Sciences
Opole, , Poland
Department of Cardiology, Poznan University of Medical Sciences
Poznan, , Poland
Department of Cardiology, The Ministry of Internal Affairs and Administration Hospital, Rzeszow
Rzeszów, , Poland
1st Department of Cardiology, Medical University of Warsaw
Warsaw, , Poland
Department of Cardiology and Internal Diseases, Military Institute of Medicine
Warsaw, , Poland
Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland
Warsaw, , Poland
Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration
Warsaw, , Poland
Department of Invasive Cardiology, Wejherowo
Wejherowo, , Poland
Centre for Heart Disease, University Hospital Wroclaw Department of Heart Disease, Wroclaw Medical University
Wroclaw, , Poland
Third Department of Cardiology, Medical University of Katowice
Zabrze, , Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wanha W, Tomaniak M, Wanczura P, Bil J, Januszek R, Wolny R, Opolski MP, Kuzma L, Janas A, Figatowski T, Gasior P, Milewski M, Roleder-Dylewska M, Lewicki L, Kulczycki J, Wlodarczak A, Tomasiewicz B, Iwanczyk S, Sacha J, Koltowski L, Dziarmaga M, Jaguszewski M, Kralisz P, Olajossy B, Sobieszek G, Dyrbus K, Lebek M, Smolka G, Reczuch K, Gil RJ, Dobrzycki S, Kwiatkowski P, Rogala M, Gasior M, Ochala A, Kochman J, Witkowski A, Lesiak M, D'Ascenzo F, Bartus S, Wojakowski W. Intravascular Lithotripsy for the Treatment of Stent Underexpansion: The Multicenter IVL-DRAGON Registry. J Clin Med. 2022 Mar 23;11(7):1779. doi: 10.3390/jcm11071779.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.